9-111371679-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_001364929.1(ECPAS):āc.4679T>Cā(p.Leu1560Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,613,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 32)
Exomes š: 0.000048 ( 0 hom. )
Consequence
ECPAS
NM_001364929.1 missense
NM_001364929.1 missense
Scores
8
6
3
Clinical Significance
Conservation
PhyloP100: 8.95
Genes affected
ECPAS (HGNC:29020): (Ecm29 proteasome adaptor and scaffold) Enables proteasome binding activity. Involved in ubiquitin-dependent ERAD pathway. Located in several cellular components, including centrosome; cytoplasmic vesicle; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.805
BS2
High AC in GnomAdExome4 at 70 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ECPAS | NM_001364929.1 | c.4679T>C | p.Leu1560Pro | missense_variant | 43/50 | ENST00000684092.1 | NP_001351858.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ECPAS | ENST00000684092.1 | c.4679T>C | p.Leu1560Pro | missense_variant | 43/50 | NM_001364929.1 | ENSP00000507419 | P4 | ||
ECPAS | ENST00000259335.8 | c.5213T>C | p.Leu1738Pro | missense_variant | 44/51 | 1 | ENSP00000259335 | |||
ECPAS | ENST00000338205.9 | c.4679T>C | p.Leu1560Pro | missense_variant | 42/49 | 5 | ENSP00000339889 | A1 | ||
ECPAS | ENST00000374383.1 | c.110T>C | p.Leu37Pro | missense_variant | 1/4 | 2 | ENSP00000363504 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152010Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152010
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 249028Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135082
GnomAD3 exomes
AF:
AC:
10
AN:
249028
Hom.:
AF XY:
AC XY:
6
AN XY:
135082
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1461610Hom.: 0 Cov.: 32 AF XY: 0.0000454 AC XY: 33AN XY: 727092
GnomAD4 exome
AF:
AC:
70
AN:
1461610
Hom.:
Cov.:
32
AF XY:
AC XY:
33
AN XY:
727092
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152010Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74226
GnomAD4 genome
AF:
AC:
1
AN:
152010
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74226
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
6
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.5213T>C (p.L1738P) alteration is located in exon 44 (coding exon 44) of the KIAA0368 gene. This alteration results from a T to C substitution at nucleotide position 5213, causing the leucine (L) at amino acid position 1738 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
.;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
T
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;.
REVEL
Pathogenic
Sift
Benign
D;D;.
Sift4G
Uncertain
D;D;D
Vest4
MutPred
0.64
.;Gain of glycosylation at L1738 (P = 0.0103);.;
MVP
MPC
0.84
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at